Inside the research

Zimmer Biomet Holdings, Inc.

ZBH Research profile · latest available data

Price overview

$91.04

▲ +1.35 (+1.5%)

52w hi$103.15
52w lo$79.37
Vol1.79M
As of25 Sep 2026

The Verdict

Hold

Our score +0.20

Short-0.03
Medium+0.31
Long+0.43

computed 2026-09-27

Key fundamentals

Zimmer Biomet Holdings, Inc.

Healthcare · Medical Devices

Market cap$17.36B
Enterprise value$24.51B
Trailing P/E22.10x
Forward P/E10.04x
EV / EBITDA9.71x
P / S (ttm)2.04x
Profit margin9.5%
Return on equity6.4%
Revenue growth+4.8%
Earnings growth+33.8%
Debt / equity60.17

Layer Breakdown

LayerRawContribution
Fundamental+0.31
Sector+0.08
Technical+0.02
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

United States · www.zimmerbiomet.com

Risk Metrics

Beta vs SPX0.29
Corr SPX0.16
Annual vol29.6%
Annual ret-3.3%
Sharpe-0.11
Max DD-29.7%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$98.52
High / Low$130.00 / $83.00
Median$95.00
Analysts21
Strong Buy2
Buy6
Hold17
Sell1
Strong Sell1

Recent rating actions

2026-04-29Wells Fargo→ Equal-Weight
2026-04-29Truist Securities→ Hold
2026-04-29Stifel→ Buy
2026-04-29JP Morgan→ Neutral
2026-04-29Citizens→ Market Outperform
2026-04-29Citigroup→ Neutral

Material Events

DateEvent8-K
2026-08-05Other Material Event, Exhibitsread
2026-08-05Earnings Release, Exhibitsread
2026-06-29Material Agreement, Termination of Agreement…read
2026-05-27Shareholder Vote, Exhibitsread
2026-05-12Reg FD Disclosure, Exhibitsread
2026-04-28Officer / Director Change, Reg FD Disclosure…read
2026-04-28Earnings Release, Exhibitsread
2026-02-10Earnings Release, Exhibitsread
2026-01-12Officer / Director Change, Exhibitsread
2025-11-05Earnings Release, Exhibitsread
2025-10-07Other Material Event, Exhibitsread
2025-09-04Other Material Eventread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-01Thornal Kevin ROfficer, Grp Pres-Global Option exercise9.96K—
2026-08-01Thornal Kevin ROfficer, Grp Pres-Global Withheld for tax4.27K$395.37K

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share99.5%
HHI3,924 (concentrated)

Top Holders

HolderValueShares
State Street Corp$766.34M8.88M
Citadel Advisors$316.10M3.67M
Capital Research / Capital World$237.49M2.76M
AQR Capital Management$31.29M367.37K
Millennium Management$19.12M222.06K
Fidelity / FMR LLC$3.93M45.69K
Bridgewater Associates$3.11M36.15K
T. Rowe Price Group$412.99K4.80M

As of 2026-06-30

Dividends

Yield (TTM)0.79%
$ / share (TTM)$0.72
5y CAGR+0.6%

Annual dividend per share

2021$0.93
2022$0.96
2023$0.96
2024$0.96
2025$0.96
2026$0.24

SEC Filings

DateFormDoc
2026-08-054view
2026-08-058-Kview
2026-08-058-Kview
2026-08-0510-Qview
2026-08-044view
2026-07-233view
2026-07-024view
2026-07-024view
2026-07-024view
2026-07-024view
2026-07-024view
2026-07-024view
2026-07-024view
2026-06-298-Kview
2026-06-034view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$7.39B+3.7%
Gross profit$1.21B-8.0%
Operating income$1.10B+0.5%
Net income$1.02B+2.2%
Cash from ops$1.58B+3.9%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$89.43$91.84$89.24$91.041.79M
Sep 24$91.43$92.51$89.02$89.692.65M
Sep 23$92.60$93.25$89.87$90.882.97M
Sep 22$95.43$95.47$93.36$93.981.71M
Sep 21$95.32$95.66$93.64$94.321.60M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →